SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : Thread Morons

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: The Street who wrote (6802)1/22/1999 8:35:00 PM
From: Tom Swift  Read Replies (1) of 12810
 
Hmm, this may explain the AZNT thread. Too much TRIM not good. Or is that Stevia?

WASHINGTON, Jan 21 (Reuters) - The U.S. Food and Drug Administration on Thursday said it was asking companies to recall dietary
supplements made with gamma butyrolactone (GBL) and urged consumers to avoid purchasing or using the products.

The FDA said it had received reports of at least one death and 55 serious health problems linked to the products, which are promoted as
helping to to build muscles, improve physical performance, reduce stress and induce sleep.

The Trimfast Group Inc (OTC BB:TRIM - news) had agreed to recall supplements containing GBL that it markets under the names Revivarant
and Revivarant G, the agency said.

Other companies were being urged to voluntarily recall the products, the FDA said. It said it would consider ''all potential regulatory actions at
its disposal'' if products were not taken off the market.

Other products containing GBL are marketed under various brand names including Renewtrient, Blue Nitro, Blue Nitro Vitality, GH Revitalizer,
Gamma G and Remforce, the FDA said in a statement.

They come in liquid and powder form and are sold via the Internet, in some health food stores and in some gymnasiums and fitness centers.

In 19 of the reported health problems linked to GBL, the consumers became unconscious or comatose, while other reported effects included
seizures, vomiting, and slow heart rate.

The FDA said that when taken orally, GBL was converted in the body to gamma hydroxybutyrate (GHB), a very potent unapproved drug that
is now being investigated as a possible treatment for narcolepsy.

''Because of its serious side effects, GHB should not be taken unless in the context of these FDA-approved investigations,'' the agency said,
noting it and the Justice Department had criminal enforcement actions running against GHB.

Consumers were advised to dispose of any products containing GBL, and to promptly contact a doctor if they had experienced any adverse
health problems.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext